Deutsche Bank Upgrades ResMed (RMD) to Buy; 2Q12 Result Give Renewed Confidence
Tweet Send to a FriendGet Alerts RMD Hot Sheet
Price: $50.08 +0.20%
Rating Summary:
3 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 25 | New: 24
Rating Summary:
3 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 25 | New: 24
Trade RMD Now!
Deutsche Bank upgraded ResMed (NYSE: RMD) from Hold to Buy, price target raised $1 to $32.00.
Deutsche analyst says, "The rebound in US device sales coupled with a lift in gross margins was encouraging, boosting our confidence that ResMed can maintain its double digit earnings growth even in the face of subdued growth in new patients numbers and keen competition. Continued double digit mask sales growth, supported by industry replenishment programs remains the key driver of earnings growth. With the stock trading well below our DCF based price target of $32 and at a discount to its historic premium to its peers we have upgraded to Buy."
For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.
Shares of ResMed closed at $27.21 yesterday, with a 52 week range of $23.37-$35.32.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Deutsche analyst says, "The rebound in US device sales coupled with a lift in gross margins was encouraging, boosting our confidence that ResMed can maintain its double digit earnings growth even in the face of subdued growth in new patients numbers and keen competition. Continued double digit mask sales growth, supported by industry replenishment programs remains the key driver of earnings growth. With the stock trading well below our DCF based price target of $32 and at a discount to its historic premium to its peers we have upgraded to Buy."
For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.
Shares of ResMed closed at $27.21 yesterday, with a 52 week range of $23.37-$35.32.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Cantor Fitzgerald Upgrades Cubist Pharmaceuticals (CBST) to Hold
- Urban Outfitters (URBN) Added to Best Ideas List at Janney Capital on Solid Q1 Results
- Macquarie Upgrades BlackRock (BLK) to Outperform
Create E-mail Alert Related Categories
UpgradesRelated Entities
Deutsche Bank, Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
